Common Contracts
11 similar null contracts by CytoCore Inc
WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUE DATE: , 200_CytoCore Inc • April 3rd, 2008 • Surgical & medical instruments & apparatus • Delaware
This certifies that , an [individual resident of ] [a with a principal business address of ] (or any valid transferee thereof, the “Holder”), for value received, is entitled to purchase from CytoCore, Inc., a Delaware corporation with its principal business office located at 414 North Orleans Street, Suite 502, Chicago, Illinois 60610 (together with its successors and assigns, the “Company”), subject to the terms and conditions set forth below, at any time or from time to time on and after the Issue Date as set forth above and before 3:00 p.m. (Eastern Daylight Time) on (the “Expiration Date”), shares of common stock, $.001 par value per share, of the Company (“Common Stock”), at a price of $ per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively.
WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUE DATE: , 200_CytoCore Inc • April 3rd, 2008 • Surgical & medical instruments & apparatus • Delaware
This certifies that , an [individual resident of ] [a with a principal business address of ] (or any valid transferee thereof, the “Holder”), for value received, is entitled to purchase from CytoCore, Inc., a Delaware corporation with its principal business office located at 414 North Orleans Street, Suite 502, Chicago, Illinois 60610 (together with its successors and assigns, the “Company”), subject to the terms and conditions set forth below, at any time or from time to time on and after the Issue Date as set forth above and before 3:00 p.m. (Eastern Daylight Time) on (the “Expiration Date”), shares of common stock, $.001 par value per share, of the Company (“Common Stock”), at a price of $ per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively.
WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUE DATE: December 8, 2006CytoCore Inc • April 3rd, 2008 • Surgical & medical instruments & apparatus • Delaware
This certifies that Cadmus Corp, a corporation with a principal business address of 3600 Rio Vista Ave., #A, Orlando, FL 32805-6605 (or any valid transferee thereof, the “Holder”), for value received, is entitled to purchase from CytoCore, Inc., a Delaware corporation with its principal business office located at 414 North Orleans Street, Suite 502, Chicago, Illinois 60610 (together with its successors and assigns, the “Company”), subject to the terms and conditions set forth below, at any time or from time to time on and after the Issue Date as set forth above and before 3:00 p.m. (Eastern Daylight Time) on July 18, 2008 (the “Expiration Date”), 1,673,077 shares of common stock, $.001 par value per share, of the Company (“Common Stock”), at a price of $0.10 per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” a
WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUE DATE: February 12, 2007CytoCore Inc • April 3rd, 2008 • Surgical & medical instruments & apparatus • Delaware
This certifies that Robert McCullough Jr., an individual resident of the State of California (or any valid transferee thereof, the “Holder”), for value received, is entitled to purchase from CytoCore, Inc., a Delaware corporation with its principal business office located at 414 North Orleans Street, Suite 502, Chicago, Illinois 60610 (together with its successors and assigns, the “Company”), subject to the terms and conditions set forth below, at any time or from time to time on and after the Issue Date as set forth above and before 3:00 p.m. (Eastern Daylight Time) on February 12, 2010 (the “Expiration Date”), Two Hundred and Fifty Thousand (250,000) shares of common stock, $.001 par value per share, of the Company (“Common Stock”), at a price of $0.26 per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and t
WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUE DATE: , 200 __CytoCore Inc • April 3rd, 2008 • Surgical & medical instruments & apparatus • Delaware
This certifies that , an [individual resident of ] [a with a principal business address of ] (or any valid transferee thereof, the “Holder”), for value received, is entitled to purchase from CytoCore, Inc., a Delaware corporation with its principal business office located at 414 North Orleans Street, Suite 502, Chicago, Illinois 60610 (together with its successors and assigns, the “Company”), subject to the terms and conditions set forth below, at any time or from time to time on and after the Issue Date as set forth above and before 3:00 p.m. (Eastern Daylight Time) on (the “Expiration Date”), shares of common stock, $.001 par value per share, of the Company (“Common Stock”), at a price of $ per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively.
WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUE DATE: December 8, 2006CytoCore Inc • April 3rd, 2008 • Surgical & medical instruments & apparatus • Delaware
This certifies that Azimuth Corporation, a corporation with a principal business address at Orlando, FL (or any valid transferee thereof, the “Holder”), for value received, is entitled to purchase from CytoCore, Inc., a Delaware corporation with its principal business office located at 414 North Orleans Street, Suite 502, Chicago, Illinois 60610 (together with its successors and assigns, the “Company”), subject to the terms and conditions set forth below, at any time or from time to time on and after the Issue Date as set forth above and before 3:00 p.m. (Eastern Daylight Time) on July 18, 2008 (the “Expiration Date”), 1,326,923 shares of common stock, $.001 par value per share, of the Company (“Common Stock”), at a price of $0.10 per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” res
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY STATE SECURITIES LAWS, AND ARE “RESTRICTED SECURITIES” AS THAT TERM IS DEFINED...CytoCore Inc • April 30th, 2007 • Surgical & medical instruments & apparatus • Delaware
This certifies that John Abeles, M.D, an individual resident of the State of Florida (or any valid Transferee thereof, the “Holder”), for value received, is entitled to purchase from CytoCore, Inc., a Delaware corporation with its principal business office located at 414 North Orleans Street, Suite 502, Chicago, Illinois 60610 (together with its successors and assigns, the “Company”), subject to the terms and conditions set forth below, at any time or from time to time on and after the Issue Date as set forth above and before 3:00 p.m. (Eastern Daylight Time) on September 28, 2011(the “Expiration Date”), Six Hundred and Twenty Five Thousand (625,000) Shares of common stock, $0.001 par value per share, of the Company (“Common Stock”), at a price of Twenty Cents ($0.20) per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant
WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUE DATE: September 28, 2006CytoCore Inc • April 30th, 2007 • Surgical & medical instruments & apparatus • Delaware
This certifies that Robert F. McCullough, Jr., an individual resident of the State of California (or any valid transferee thereof, the “Holder”), for value received, is entitled to purchase from CytoCore, Inc., a Delaware corporation with its principal business office located at 414 North Orleans Street, Suite 502, Chicago, Illinois 60610 (together with its successors and assigns, the “Company”), subject to the terms and conditions set forth below, at any time or from time to time on and after the Issue Date as set forth above and before 3:00 p.m. (Eastern Daylight Time) on September 28, 2009 (the “Expiration Date”), Four Million (4,000,000) Shares of common Stock, $0.001 par value per share, of the Company (“Common Stock”), at a price of Twelve and Three Quarter Cents ($0.1275) per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as t
WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUE DATE: December 1, 2006CytoCore Inc • April 30th, 2007 • Surgical & medical instruments & apparatus • Delaware
This certifies that Dr. Augusto Ocana, an individual resident of the State of New Jersey (the “Holder”), for value received, is entitled to purchase from CytoCore, Inc., a Delaware corporation with its principal business office located at 414 North Orleans Street, Suite 502, Chicago, Illinois 60610 (together with its successors and assigns, the “Company”), subject to the terms and conditions set forth below, at any time or from time to time on and after the Issue Date as set forth above and before 3:00 p.m. (Eastern Time) on December 1, 2009 (the “Expiration Date”), Five Hundred Thousand (500,000) shares of common stock, $.001 par value per share, of the Company (“Common Stock”), at a price per share of $0.13. The shares purchasable upon exercise of this Warrant, and the applicable purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively.
WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUE DATE: , 200_CytoCore Inc • April 17th, 2007 • Surgical & medical instruments & apparatus • Delaware
This certifies that , an [individual resident of ] [a with a principal business address of ] (or any valid transferee thereof, the “Holder”), for value received, is entitled to purchase from CytoCore, Inc., a Delaware corporation with its principal business office located at 414 North Orleans Street, Suite 502, Chicago, Illinois 60610 (together with its successors and assigns, the “Company”), subject to the terms and conditions set forth below, at any time or from time to time on and after the Issue Date as set forth above and before 3:00 p.m. (Eastern Daylight Time) on (the “Expiration Date”), shares of common stock, $.001 par value per share, of the Company (“Common Stock”), at a price of $0.18 per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively.
WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUE DATE: September 28, 2006CytoCore Inc • April 17th, 2007 • Surgical & medical instruments & apparatus • Delaware
This certifies that Alexander M. Milley, an individual resident of Massachusetts (or any valid transferee thereof, the “Holder”), for value received, is entitled to purchase from CytoCore, Inc., a Delaware corporation with its principal business office located at 414 North Orleans Street, Suite 502, Chicago, Illinois 60610 (together with its successors and assigns, the “Company”), subject to the terms and conditions set forth below, at any time or from time to time on and after the Issue Date as set forth above and before 3:00 p.m. (Eastern Daylight Time) on September 28, 2011 (the “Expiration Date”), Six Hundred and Twenty Five Thousand (625,000) shares of common Stock, $0.001 par value per share, of the Company (“Common Stock”), at a price of Twenty Cents ($0.20) per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Sh
